I take this to mean no side effects and patient has tolerated the initial treatment, being that phase 1 was efficacy etc. That is good as if palatability issues re raised its head then that would have been a significant backward step. This may also be why the faster movement to interim analysis.
Good on FightMND and PAA for getting the next cohort filled. Hopefully we see the 10c mark again.
- Forums
- ASX - By Stock
- Ann: MND Trial Completes Enrolment of Cohort 2
I take this to mean no side effects and patient has tolerated...
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $87.89M |
Open | High | Low | Value | Volume |
20.0¢ | 20.0¢ | 19.5¢ | $60.59K | 304K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 578044 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 538951 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 565250 | 0.195 |
15 | 601584 | 0.190 |
24 | 1078524 | 0.185 |
18 | 953238 | 0.180 |
6 | 421143 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 638951 | 4 |
0.205 | 55115 | 3 |
0.210 | 111508 | 5 |
0.215 | 233021 | 5 |
0.220 | 134118 | 2 |
Last trade - 12.41pm 11/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |